The EGLN1 gene helps your body sense oxygen levels and adjust how strongly it responds when oxygen is low. This gene helps your body avoid making an oxygen alarm signal at the wrong time. If it does not work properly, the body may act as if oxygen is scarce even when it is not, which can raise red blood cell levels and in some people lead to familial erythrocytosis. Some variants in the EGLN1 gene are also linked to natural adaptation to life at high altitude, especially in Tibetan populations, which has made this gene better known in research on human endurance and altitude.
What is a gene?
A gene is a piece of DNA that carries instructions cells use to make molecules or guide processes throughout the body. Some genes provide the code for proteins, which do much of the cell’s work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can read more in the LearnHub.
Overview
EGLN1Gene function
What if the gene works
The EGLN1 gene helps your body sense oxygen levels. It helps control how cells respond when oxygen is low, including signals that affect red blood cell production and energy use.
Risk
What if the gene does not work
Variants in the EGLN1 gene are best known for causing inherited erythrocytosis, with higher than usual red blood cell levels. Effects can range from mild to more marked, which may influence when problems appear and how noticeable they are.
Treatment
What does that mean for your treatment
No EGLN1-specific treatment or drug selection approach is currently established in clinical guidelines. The EGLN1 gene is part of the body’s oxygen-sensing pathway, and this pathway is being targeted in drug development; medicines that block related proteins are used for some forms of anemia, but that is not a gene-specific treatment for people with an EGLN1 variant.
Conditions associated with EGLN1
Gene function
What if the gene works
Your cells constantly track how much oxygen is available. The EGLN1 gene helps manage that process so tissues can match daily needs, from quiet rest to exercise. In everyday terms, it is part of how the body senses oxygen and fine tunes its response.
The EGLN1 gene helps cells measure available oxygen throughout the day. When oxygen is plentiful, its protein places a small chemical tag on oxygen response proteins so they can be cleared away.
This tagging keeps oxygen response signals quiet under usual conditions. It helps cells switch on extra low oxygen programs only when they are truly needed.
By guiding oxygen signaling, this gene helps match red blood cell production to your body's needs. It also supports normal signals that shape blood vessel growth and tissue adjustment during exercise or high altitude.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variations in appearance, metabolism, and the way the body responds to environmental influences. Many do not lead to any noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant changes how a gene functions more substantially and may contribute to or directly cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the EGLN1 gene can weaken or reshape the PHD2 protein, changing how cells sense oxygen. This is how EGLN1 variants affect oxygen sensing: reduced PHD2 activity can leave HIF switched on longer than it should be, which may increase signals that promote red blood cell production. Milder variants may only partly reduce protein activity, while more severe variants can markedly disrupt folding, stability, or the active site and are often linked to earlier or more marked erythrocytosis.
How variants are linked to conditions
Pathogenic variants in the EGLN1 gene are a known cause of familial erythrocytosis type 3, an inherited condition with persistently high red blood cell levels. In population studies, common EGLN1 variants have also been linked to differences in hemoglobin levels and to high altitude adaptation, especially in Tibetan populations. These common variants influence traits and risk patterns rather than confirming a diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For some EGLN1 changes linked to unusually high red blood cell levels, anything that lowers oxygen in the body can make symptoms or complications more likely. This can include smoking, sleep apnea, lung or heart problems, and living at high altitude.
Inheritance of EGLN1 variants
For families asking how EGLN1 gene variants are inherited, the best established pattern is autosomal dominant for EGLN1-related familial erythrocytosis. This means a parent with a disease-causing variant in the EGLN1 gene can pass it to a child, son or daughter, with a 50% chance in each pregnancy. A person only needs one altered copy of the gene to inherit this condition. The variant can be passed from either side of the family.
What does my EGLN1 result mean for my family?
For EGLN1, a disease-causing result is most often linked to a dominantly inherited condition that can raise red blood cell levels. This means close relatives, such as a parent, brother, sister, or child, may also carry the same change and could have similar blood findings, even if they feel well. In families with a confirmed EGLN1-related condition, relatives may want to discuss whether the result is relevant for them.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the EGLN1 gene, a lab can analyze DNA from a blood sample, saliva, or cheek swab. Genetic testing for EGLN1 variants reads the gene's code and compares it with the usual sequence to identify variants, which are then classified by their likely health effect.
When should I consider getting a genetic test?
Consider testing for the EGLN1 gene if you or close relatives have an unexplained, lifelong high red blood cell count, sometimes called erythrocytosis. It can be especially relevant when common causes such as smoking, lung disease, heart disease, or living at high altitude do not explain the finding.
A genetic result is only one part of your health story
A genetic result can provide useful information, but how informative it is depends on the condition and on the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, influence how the body works over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is broken down, how strongly it works, or how sensitive your body is to side effects. This is a common reason why the same treatment may help one person more than another, even when they take the same medication in the same way.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic variation can shape a person’s response to medication. By examining connections between genes and drugs, it helps clarify why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the EGLN1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication use. If you have concerns about side effects, new symptoms after starting a medicine, or how your treatments may affect your health, talk with your doctor or pharmacist.
History
The EGLN1 gene entered modern genetics through work on how cells sense oxygen, a question that drew major research interest in the late 1990s and early 2000s. Scientists studying the HIF pathway identified EGLN1, also called PHD2, as one of the key genes in this oxygen sensing system. From these first observations, research expanded steadily. Interest in the EGLN1 gene also grew through studies of people living at very high altitude, especially Tibetan populations, where inherited variants were linked to adaptation to thinner air. This broader field gained worldwide attention when discoveries about cellular oxygen sensing were recognized with the 2019 Nobel Prize in Physiology or Medicine. Today, the EGLN1 gene is remembered as part of both a landmark basic science story and an important chapter in human adaptation research.